Efinaconazole 100 MG/ML Topical Solution [Jublia] — RxCUI 1539762
RxNorm drug concept · Semantic branded drug
RxCUI 1539762
Semantic branded drug · SBD
● Current RxNorm concept 1 FDA product
3 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1539762
Official nameEfinaconazole 100 MG/ML Topical Solution [Jublia]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asJublia 10 % Topical Solution
FDA products mapped1
Package NDCs mapped3
Reported Medicaid activity (SDUD)19,808 prescriptions · 28 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Efinaconazole Topical: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Jublia treats onychomycosis — a fungal infection that gets into your toenail and causes it to look thick, discolored, or crumbly. It targets two specific fungi, Trichophyton rubrum...
- What exactly is Jublia treating on my toenail?
- Yes, and that's completely normal to wonder about. Toenails grow very slowly, so it takes a full 48 weeks for the healthy nail to grow in and replace the infected one. Stopping ear...
- Do I really have to use it for 48 weeks? That seems like a long time.
🕸️ Concept Web — How Efinaconazole 100 MG/ML Topical Solution [Jublia... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Efinaconazole 100 MG/ML Topical Solution [Jublia]
RxCUI 1539762 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Efinaconazole
1539753IN
-
Efinaconazole
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Jublia
1539758BN
-
Jublia
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Efinaconazole Topical Solution
1539756SCDF -
Efinaconazole Topical Product
1539755SCDG -
Efinaconazole Topical Solution [Jublia]
1539760SBDF -
Jublia Topical Product
1539761SBDG -
Topical Solution
316986DF -
Topical Product
1151122DFG
-
Efinaconazole Topical Solution
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Efinaconazole 100 MG/ML Topical Solution
1539757SCD -
Efinaconazole 100 MG/ML
1539754SCDC -
Efinaconazole 100 MG/ML [Jublia]
1539759SBDC
-
Efinaconazole 100 MG/ML Topical Solution
Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Efinaconazole 100 MG/ML Topical Solution
SCD · 1539757 -
Efinaconazole 100 MG/ML
SCDC · 1539754 -
Efinaconazole Topical Solution
SCDF · 1539756 -
Efinaconazole Topical Product
SCDG · 1539755
Brand-Name Concepts
-
Efinaconazole 100 MG/ML [Jublia]
SBDC · 1539759 -
Efinaconazole Topical Solution [Jublia]
SBDF · 1539760 -
Jublia Topical Product
SBDG · 1539761 -
Jublia
BN · 1539758
📦 FDA Products & Package NDCs
1 product · 3 package NDCs
3 package NDCs map to RxCUI 1539762 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00187-5400-02 | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (0187-5400-02) / 2 mL... | JUBLIA | Bausch Health US LLC | 2015-12-17 |
| 00187-5400-04 | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (0187-5400-04) / 4 mL... | JUBLIA | Bausch Health US LLC | 2014-06-06 |
| 00187-5400-08 | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (0187-5400-08) / 8 mL... | JUBLIA | Bausch Health US LLC | 2014-06-06 |
Observed labelers:
Bausch Health US LLC (3)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.